Clinical Trial Update: Multiple Ascending Doses of ZP4207 Administered to HV to Evaluate the Safety, Tolerability, PKs and PDs of ZP4207 [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting multiple ascending doses of ZP4207 in healthy volunteers to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia

Drugs mentioned

• ZP4207

Snippet

Sponsor: Zealand Pharma | Conditions: Hypoglycemia | Phase 1 | Status: COMPLETED